Cargando…

P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma

We evaluated the safety and immunogenicity of the BNT162b2 vaccine in 52 patients with multiple myeloma (MM). Median age was 71.3 (range, 39.6-90.8) years. 26 (50%) patients had received active treatment including an immunomodulatory drug (IMiD) (n=21), an anti-CD38 monoclonal antibody (n=11) and/or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malard, Florent, Gaugier, Béatrice, Gozlan, Joel, Bouquet, Lucie, Fofana, Djeneba, Van De Wyngaert, Zoe, Ikhlef, Souhila, Marjanovitch, Zora, Morand-Joubert, Laurence, Mohty, Mohamad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580180/ http://dx.doi.org/10.1016/S2152-2650(21)02276-X

Ejemplares similares

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Malard, Florent, et al.
Publicado: (2021)

COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease
por: Alsuliman, Tamim, et al.
Publicado: (2022)

COVID-19 outcomes in patients with hematologic disease
por: Malard, Florent, et al.
Publicado: (2020)

Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?
por: Alsuliman, Tamim, et al.
Publicado: (2021)

Management of patients with multiple myeloma during the COVID-19 pandemic
por: Malard, Florent, et al.
Publicado: (2020)

Daratumumab prevents programmed death ligand‐1 expression on antigen‐presenting cells in de novo multiple myeloma
por: Stocker, Nicolas, et al.
Publicado: (2020)

Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
por: Mohty, Mohamad, et al.
Publicado: (2020)

Current status of autologous stem cell transplantation for multiple myeloma
por: Al Hamed, Rama, et al.
Publicado: (2019)

Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies
por: El-Cheikh, Jean, et al.
Publicado: (2023)

Plasmacytoid dendritic cell biology and its role in immune‐mediated diseases
por: Ye, Yishan, et al.
Publicado: (2020)

Introduction to host microbiome symbiosis in health and disease
por: Malard, Florent, et al.
Publicado: (2020)

New Insight for the Diagnosis of Gastrointestinal Acute Graft-versus-Host Disease
por: Malard, Florent, et al.
Publicado: (2014)

Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases
por: Otiniano, Armelle, et al.
Publicado: (2022)

Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03)
por: van de Wyngaert, Zoe, et al.
Publicado: (2023)

Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements
por: Malagnino, Vincenzo, et al.
Publicado: (2018)

Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value
por: Schnuriger, Aurélie, et al.
Publicado: (2021)

Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Lamarthée, Baptiste, et al.
Publicado: (2016)

Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update
por: Bazarbachi, Abdul Hamid, et al.
Publicado: (2022)

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
por: Marot, Stephane, et al.
Publicado: (2022)

Posttransplant maintenance therapy in multiple myeloma: the changing landscape
por: Sengsayadeth, S, et al.
Publicado: (2017)

High‐dose post‐transplant cyclophosphamide impairs γδ T‐cell reconstitution after haploidentical haematopoietic stem cell transplantation using low‐dose antithymocyte globulin and peripheral blood stem cell graft
por: Stocker, Nicolas, et al.
Publicado: (2020)

Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant
por: Bazarbachi, Abdul Hamid, et al.
Publicado: (2019)

TFH cells in systemic sclerosis
por: Beurier, Pauline, et al.
Publicado: (2021)

Decay chain $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm
por: Cabrera, J A, et al.
Publicado: (1991)

Immunotherapy for Multiple Myeloma
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Comprehensive Review of AL amyloidosis: some practical recommendations
por: Al Hamed, Rama, et al.
Publicado: (2021)

Study of $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm decay chain
por: Cabrera, J A, et al.
Publicado: (1992)

Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation
por: Duléry, Rémy, et al.
Publicado: (2021)

Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment
por: Oganesyan, Artem, et al.
Publicado: (2022)

Arsenic trioxide induces regulatory functions of plasmacytoid dendritic cells through interferon-α inhibition
por: Ye, Yishan, et al.
Publicado: (2020)

Hepatitis B Virus in West African Children: Systematic Review and Meta-Analysis of HIV and Other Factors Associated with Hepatitis B Infection
por: Fofana, Djeneba B., et al.
Publicado: (2023)

Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa
por: Jarry, Anne, et al.
Publicado: (2016)

Emission channeling experiments from the decay of $^{149}$Gd to $^{149}$Eu in GaN
por: De Vries, B, et al.
Publicado: (2003)

149th SPSC Meeting
Publicado: (2023)

149th LHCC Meeting
Publicado: (2022)

High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies
por: Boukli, Narjis, et al.
Publicado: (2020)

INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels
por: Lambert-Niclot, Sidonie, et al.
Publicado: (2019)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
por: Zhang, Lu, et al.
Publicado: (2012)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma
por: Johnstone, Megan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tk7koi1fss9aflagu63ei9g078